Migration, proliferation, and differentiation of cord blood mesenchymal stromal cells treated with histone deacetylase inhibitor valproic acid

Stem Cells International

Volumn 2014, Issue , 2014, Pages

  Marquez Curtis, Leah A ^a   Qiu, Yuanyuan ^a   Xu, April ^a   Janowska Wieczorek, Anna ^a,b  

^a CANADIAN BLOOD SERVICES   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; CHEMOKINE RECEPTOR CXCR7; COLLAGEN TYPE 10; GELATINASE A; MATRIX METALLOPROTEINASE 14; MESSENGER RNA; MYOD PROTEIN; MYOGENIN; OCTAMER TRANSCRIPTION FACTOR 4; OSTEOCALCIN; STROMAL CELL DERIVED FACTOR 1; TRANSCRIPTION FACTOR OSTERIX; TRANSCRIPTION FACTOR SOX2; VALPROIC ACID;

ARTICLE; CARTILAGE CELL; CELL DIFFERENTIATION; CELL MIGRATION; CELL PROLIFERATION; CELL RENEWAL; CELL STIMULATION; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; ENZYME RELEASE; EX VIVO STUDY; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; INTRACELLULAR SIGNALING; MESENCHYMAL STROMA CELL; MMP2 GENE; MOLECULAR DYNAMICS; MUSCLE CELL; OSTEOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; UMBILICAL CORD BLOOD; UPREGULATION;

EID: 84897477328     PISSN: None     EISSN: 16879678     Source Type: Journal    
DOI: 10.1155/2014/610495     Document Type: Article

References (43)

1. Clinical Trials.Gov,. 2014
2. Son B.-R., Marquez-Curtis L. A., Kucia M., Wysoczynski M., Turner A. R., Ratajczak J., Ratajczak M. Z., Janowska-Wieczorek A., Migration of bone marrow and cord blood mesenchymal stem cells in vitro is regulated by stromal-derived factor-1-CXCR4 and hepatocyte growth factor-c-met axes and involves matrix metalloproteinases. Stem Cells 2006 24 5 1254 1264 2-s2.0-33749078198 10.1634/stemcells.2005-0271 (Pubitemid 44464694)
3. Kitaori T., Ito H., Schwarz E. M., Tsutsumi R., Yoshitomi H., Oishi S., Nakano M., Fujii N., Nagasawa T., Nakamura T., Stromal cell-derived factor 1/CXCR4 signaling is critical for the recruitment of mesenchymal stem cells to the fracture site during skeletal repair in a mouse model. Arthritis and Rheumatism 2009 60 3 813 823 2-s2.0-61649090805 10.1002/art.24330
4. Liu H., Liu S., Li Y., The role of SDF-1-CXCR4/CXCR7 axis in the therapeutic effects of hypoxia-preconditioned mesenchymal stem cells for renal ischemia/reperfusion injury. PLoS One 2012 7 4 e34608
5. Gao J., Dennis J. E., Muzic R. F., Lundberg M., Caplan A. I., The dynamic in vivo distribution of bone marrow-derived mesenchymal stem cells after infusion. Cells Tissues Organs 2001 169 1 12 20 2-s2.0-0035010796 10.1159/000047856 (Pubitemid 32437040)
6. Honczarenko M., Le Y., Swierkowski M., Ghiran I., Glodek A. M., Silberstein L. E., Human bone marrow stromal cells express a distinct set of biologically functional chemokine receptors. Stem Cells 2006 24 4 1030 1041 2-s2.0-33745489036 10.1634/stemcells.2005-0319 (Pubitemid 44464736)
7. Wynn R. F., Hart C. A., Corradi-Perini C., O'Neill L., Evans C. A., Wraith J. E., Fairbairn L. J., Bellantuono I., A small proportion of mesenchymal stem cells strongly expresses functionally active CXCR4 receptor capable of promoting migration to bone marrow. Blood 2004 104 9 2643 2645 2-s2.0-7244224904 10.1182/blood-2004-02-0526 (Pubitemid 39434942)
8. Qiu Y., Marquez-Curtis L. A., Janowska-Wieczorek A., Mesenchymal stromal cells derived from umbilical cord blood migrate in response to complement C1q. Cytotherapy 2012 14 3 285 295 2-s2.0-84856928657 10.3109/14653249.2011.651532
9. Marquez-Curtis L. A., Gul-Uludag H., Xu P., Chen J., Janowska-Wieczorek A., CXCR4 transfection of cord blood mesenchymal stromal cells with the use of cationic liposome enhances their migration toward stromal cell-derived factor-1. Cytotherapy 2013 15 7840 9 10.1016/j.jcyt.2013.02.009
10. Gul H., Marquez-Curtis L. A., Jahroudi N., Lo J., Turner A. R., Janowska-Wieczorek A., Valproic acid increases CXCR4 expression in hematopoietic stem/progenitor cells by chromatin remodeling. Stem Cells and Development 2009 18 6 831 838 2-s2.0-67651119931 10.1089/scd.2008.0235
11. Marquez-Curtis L. A., Turner A. R., Sridharan S., Ratajczak M. Z., Janowska-Wieczorek A., The ins and outs of hematopoietic stem cells: studies to improve transplantation outcomes. Stem Cell Reviews and Reports 2011 7 3 590 607 2-s2.0-79960315548 10.1007/s12015-010-9212-8
12. New M., Olzscha H., La Thangue N. B., HDAC inhibitor-based therapies: can we interpret the code? Molecular Oncology 2012 6 6 637 656
13. Koch-Weser J., Browne T. R., Drug therapy: valproic acid. The New England Journal of Medicine 1980 302 12 661 666
14. Tsai L.-K., Leng Y., Wang Z., Leeds P., Chuang D.-M., The mood stabilizers valproic acid and lithium enhance mesenchymal stem cell migration via distinct mechanisms. Neuropsychopharmacology 2010 35 11 2225 2237 2-s2.0-78651280399 10.1038/npp.2010.97
15. Balabanian K., Lagane B., Infantino S., Chow K. Y. C., Harriague J., Moepps B., Arenzana-Seisdedos F., Thelen M., Bachelerie F., The chemokine SDF-1/CXCL12 binds to and signals through the orphan receptor RDC1 in T lymphocytes. The Journal of Biological Chemistry 2005 280 42 35760 35766 2-s2.0-27444443142 10.1074/jbc.M508234200 (Pubitemid 41532769)
16. Gao H., Priebe W., Glod J., Banerjee D., Activation of signal transducers and activators of transcription 3 and focal adhesion kinase by stromal cell-derived factor 1 is required for migration of human mesenchymal stem cells in response to tumor cell-conditioned medium. Stem Cells 2009 27 4 857 865 2-s2.0-65649149328 10.1002/stem.23
17. Bug G., Gül H., Schwarz K., Pfeifer H., Kampfmann M., Zheng X., Beissert T., Boehrer S., Hoelzer D., Ottmann O. G., Ruthardt M., Valproic acid stimulates proliferation and self-renewal of hematopoietic stem cells. Cancer Research 2005 65 7 2537 2541 2-s2.0-20144388533 10.1158/0008-5472.CAN-04-3011 (Pubitemid 40490047)
18. Lee S., Park J.-R., Seo M.-S., Roh K.-H., Park S.-B., Hwang J.-W., Sun B., Seo K., Lee Y.-S., Kang S.-K., Jung J.-W., Kang K.-S., Histone deacetylase inhibitors decrease proliferation potential and multilineage differentiation capability of human mesenchymal stem cells. Cell Proliferation 2009 42 6 711 720 2-s2.0-70350461683 10.1111/j.1365-2184.2009.00633.x
19. Dominici M., Le Blanc K., Mueller I., Slaper-Cortenbach I., Marini F. C., Krause D. S., Deans R. J., Keating A., Prockop D. J., Horwitz E. M., Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 2006 8 4 315 317 2-s2.0-33747713246 10.1080/14653240600855905 (Pubitemid 44269669)
20. Manca M. F., Zwart I., Beo J., Palasingham R., Jen L.-S., Navarrete R., Girdlestone J., Navarrete C. V., Characterization of mesenchymal stromal cells derived from full-term umbilical cord blood. Cytotherapy 2008 10 1 54 68 2-s2.0-38349150344 10.1080/14653240701732763
21. Zhang Y., Foudi A., Geay J.-F., Berthebaud M., Buet D., Jarrier P., Jalil A., Vainchenker W., Louache F., Intracellular localization and constitutive endocytosis of CXCR4 in human CD34+ hematopoietic progenitor cells. Stem Cells 2004 22 6 1015 1029 2-s2.0-8644249116 (Pubitemid 39507088)
22. Levoye A., Balabanian K., Baleux F., Bachelerie F., Lagane B., CXCR7 heterodimerizes with CXCR4 and regulates CXCL12-mediated G protein signaling. Blood 2009 113 24 6085 6093 2-s2.0-67650349084 10.1182/blood-2008-12-196618
23. Shirvaikar N., Marquez-Curtis L. A., Ratajczak M. Z., Janowska-Wieczorek A., Hyaluronic acid and thrombin upregulate MT1-MMP through PI3K and Rac-1 signaling and prime the homing-related responses of cord blood hematopoietic stem/progenitor cells. Stem Cells and Development 2011 20 1 19 30 2-s2.0-78650971739 10.1089/scd.2010.0118
24. Nakashima K., Zhou X., Kunkel G., Zhang Z., Deng J. M., Behringer R. R., de Crombrugghe B., The novel zinc finger-containing transcription factor Osterix is required for osteoblast differentiation and bone formation. Cell 2002 108 1 17 29 2-s2.0-0037059614 10.1016/S0092-8674(01)00622-5 (Pubitemid 34137009)
25. Kapustin A. N., Shanahan C. M., Osteocalcin: a novel vascular metabolic and osteoinductive factor? Arteriosclerosis, Thrombosis, and Vascular Biology 2011 31 10 2169 2171 2-s2.0-80053046842 10.1161/ATVBAHA.111.233601
26. Shen G., The role of type X collagen in facilitating and regulating endochondral ossification of articular cartilage. Orthodontics & Craniofacial Research 2005 8 1 11 17 2-s2.0-14544274227
27. Jalili A., Marquez-Curtis L., Shirvaikar N., Wysoczynski M., Ratajczak M., Janowska-Wieczorek A., Complement C1q enhances homing-related responses of hematopoietic stem/progenitor cells. Transfusion 2010 50 9 2002 2010 2-s2.0-77956313117 10.1111/j.1537-2995.2010.02664.x
28. Shi M., Li J., Liao L., Chen B., Li B., Chen L., Jia H., Zhao R. C., Regulation of CXCR4 expression in human mesenchymal stem cells by cytokine treatment: role in homing efficiency in NOD/SCID mice. Haematologica 2007 92 7 897 904 2-s2.0-34548790066 10.3324/haematol.10669 (Pubitemid 350144236)
29. Kyriakou C., Rabin N., Pizzey A., Nathwani A., Yong K., Factors that influence short-term homing of human bone marrow-derived mesenchymal stem cells in a xenogeneic animal model. Haematologica 2008 93 10 1457 1465 2-s2.0-54349101485 10.3324/haematol.12553
30. Gheisari Y., Azadmanesh K., Ahmadbeigi N., Genetic modification of mesenchymal stem cells to overexpress CXCR4 and CXCR7 does not improve the homing and therapeutic potentials of these cells in experimental acute kidney injury. Stem Cells and Development 2012 21 16 2969 2980
31. Tsai L.-K., Wang Z., Munasinghe J., Leng Y., Leeds P., Chuang D.-M., Mesenchymal stem cells primed with valproate and lithium robustly migrate to infarcted regions and facilitate recovery in a stroke model. Stroke 2011 42 10 2932 2939 2-s2.0-80053309997 10.1161/STROKEAHA.110.612788
32. de Becker A., Van Hummelen P., Bakkus M., Broek I. V., de Wever J., de Waele M., Van Riet I., Migration of culture-expanded human mesenchymal stem cells through bone marrow endothelium is regulated by matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-3. Haematologica 2007 92 4 440 449 2-s2.0-34547650992 10.3324/haematol.10475 (Pubitemid 350144289)
33. Tondreau T., Meuleman N., Stamatopoulos B., de Bruyn C., Delforge A., Dejeneffe M., Martiat P., Bron D., Lagneaux L., In vitro study of matrix metalloproteinase/tissue inhibitor of metalloproteinase production by mesenchymal stromal cells in response to inflammatory cytokines: the role of their migration in injured tissues. Cytotherapy 2009 11 5 559 569 2-s2.0-70849093289 10.1080/14653240903051541
34. Schroeder T. M., Westendorf J. J., Histone deacetylase inhibitors promote osteoblast maturation. Journal of Bone and Mineral Research 2005 20 12 2254 2263 2-s2.0-28144448363 10.1359/JBMR.050813 (Pubitemid 41698788)
35. Hatakeyama Y., Hatakeyama J., Takahashi A., The effect of valproic acid on mesenchymal pluripotent cell proliferation and differentiation in extracellular matrices. Drug Target Insights 2011 5 1 9
36. Moschidou D., Mukherjee S., Blundell M. P., Valproic acid confers functional pluripotency to human amniotic fluid stem cells in a transgene-free approach. Molecular Therapy 2012 20 10 1953 1967
37. Kretsovali A., Hadjimichael C., Charmpilas N., Histone deacetylase inhibitors in cell pluripotency, differentiation, and reprogramming. Stem Cells International 2012 2012 10 2-s2.0-84859744612 10.1155/2012/184154 184154
38. Huangfu D., Maehr R., Guo W., Eijkelenboom A., Snitow M., Chen A. E., Melton D. A., Induction of pluripotent stem cells by defined factors is greatly improved by small-molecule compounds. Nature Biotechnology 2008 26 7 795 797 2-s2.0-46949085597 10.1038/nbt1418 (Pubitemid 351961456)
39. Caplan A. I., Dennis J. E., Mesenchymal stem cells as trophic mediators. Journal of Cellular Biochemistry 2006 98 5 1076 1084 2-s2.0-33746424373 10.1002/jcb.20886 (Pubitemid 44128350)
40. Hu N., Wang C., Liang X., Inhibition of histone deacetylases potentiates BMP9-induced osteogenic signaling in mouse mesenchymal stem cells. Cellular Physiology and Biochemistry 2013 32 2 486 498
41. Jung J.-W., Lee S., Seo M.-S., Park S.-B., Kurtz A., Kang S.-K., Kang K.-S., Histone deacetylase controls adult stem cell aging by balancing the expression of polycomb genes and jumonji domain containing 3. Cellular and Molecular Life Sciences 2010 67 7 1165 1176 2-s2.0-77950602854 10.1007/s00018-009-0242-9
42. Paino F., La Noce M., Tirino V., Histone deacetylase inhibition with valproic acid downregulates osteocalcin gene expression in human dental pulp stem cells and osteoblasts: evidence for HDAC2 involvement. Stem Cells 2014 32 1 279 289
43. Jeong S. G., Ohn T., Kim S. H., Cho G. W., Valproic acid promotes neuronal differentiation by induction of neuroprogenitors in human bone-marrow mesenchymal stromal cells. Neuroscience Letters 2013 554 22 27